Enigma Diagnostics Limited (in liquidation) & Ors v Harvey Boulter & Ors

BACKGROUND

The Claimants in this matter are Enigma Diagnostics Limited ("Enigma"), a company in liquidation and its liquidators. Before going into liquidation, Enigma was a start-up company engaged in developing medical diagnostic equipment, commercialising technology originally developed by the Ministry of Defence.

The Claimants are pursuing claims based on a number of causes of action against the First Defendant, Mr Boulter, and the law firm used by him and his companies, which is the Second Defendant, DLA Piper UK LLP ("DLA Piper") as well as against one of the members of that firm who had conduct of matters instructed by Mr Boulter, the Third Defendant, Mr Cook.

It is not necessary for the purposes of this application to describe the nature of the claims made in detail, beyond saying that the Claimants allege that Mr Boulter acted wrongfully in relation to his dealings in shares of Enigma, via Porton Capital Limited ("PCL"), a company owned and controlled by him.

PCL was a company based in the Cayman Islands but has been dissolved since the time of the matters in question. Mr Boulter arranged for shares in Enigma to be issued to PCL and subsequently sold by PCL at a higher price, an arrangement that the Claimants describe as the "Enigma Investment Scheme". The Claimants allege that he did so whilst he and PCL were under fiduciary and/or contractual duties to obtain the best price for the shares for the benefit of Enigma.

The Claimants are also making claims against DLA Piper and Mr Cook in relation to their involvement in these arrangements.

There is no dispute in relation to the basic facts that Enigma issued shares to PCL and PCL sold beneficial interests in those shares to third parties (whom I will refer to as "Investors"), with PCL remaining on the share register as nominee for individual Investors. The matter disputed is whether it was entitled to do so without passing the entire sale proceeds, less commission, to Enigma rather than keeping a substantial profit for itself.

The Defendants object to the characterisation of these arrangements for investment as a "scheme" with the pejorative connotations that come with that word. For convenience, I will use the Claimants' nomenclature but this should not be taken at this stage, before the substantive matter has been tried, as any endorsement of any pejorative connotations that may be associated with this terminology.

By way of background to their claim, the Claimants allege that Mr Boulter wrongfully undertook similar schemes of investment in relation to certain other companies that were in the development stage and in need of capital. The Claimants refer to these companies as the "Porton Portfolio Companies" and I will use the same term. This term refers to any companies in respect of which PCL sold shares where DLA Piper was involved in that sale.

The case before me today deals with an application for an order that:

This application is particularly important to the Claimants in this case as Enigma no longer holds its files relevant to these points and the First Defendant also claims to have lost much of his documentation. DLA Piper therefore is the only party left holding substantial contemporary documentation.

The basis for this application is that the Claimants consider that Mr Boulter and PCL are not entitled to legal professional privilege on the grounds of iniquity. The Claimants ask the court to base a finding in relation to iniquity on their contention that the Enigma Investment Scheme, and the similar arrangements made in respect of the other Porton Portfolio Companies, involved a fraud on the Investors that purchased shares from PCL.

The Claimants have helpfully provided a draft order that they invite the court to make. The Second and Third Defendants are neither resisting nor accepting the Claimants' argument but agree that if the court does find that legal professional privilege has been lost by reason of iniquity, that order is an appropriate one to make.

At this hearing the Claimants were represented by Mr Neil Kitchener KC and Mr Tom Foxton of counsel, and the Second and Third Defendants were represented by Patricia Robertson KC, and these counsel also provided helpful skeleton arguments.

The First Defendant did not attend this hearing, despite having notice of it. His solicitors, Kobre & Kim, wrote to the Claimants' solicitors, Macfarlanes on 26 May 2023 stating that, although Mr Boulter did not accept that there was any fraudulent conduct, he did not intend to play any substantive role in the hearing of the application.

Kobre & Kim had been copied into a significant amount of the correspondence prior to this application and Mr Boulter had ample opportunities to answer the allegations that form the basis of this application.

Mr Boulter has not asked for any adjournment and I see no reason not to proceed with this hearing, so I have seen no reason not to proceed with the hearing despite his not attending and not being represented here.

LEGAL PROFESSIONAL PRIVILEGE

The principles underlying legal professional privilege and the circumstances where this may be lost are well settled. I was referred by counsel amongst other cases to the summaries of the relevant legal principles by the Court of Appeal in Addlesee v Dentons Europe LLP [2020] EWHC 238 (CH) ("Addlesee 1"); by Master Clark in relation to the same case at a later stage reported at 2020 EWHC 238 (Ch) ("Addlesee 2") and by Murray J in Al Sadeq v Dechert LLP & Ors [2023] EWHC 795 (KB) ("Al Sadeq").

For the present purposes, I will just highlight a few matters.

THE EVIDENCE RELIED UPON

For the present purposes the Claimants are not relying on the breaches of duty and/or contract and/or trust that they allege in their Amended Particulars of Claim as the basis for finding iniquity sufficient to displace legal professional privilege. They instead base this on evidence they brought before the court that the Enigma Investment Scheme and similar schemes in relation to the Porton Portfolio Companies involved a fraud on Investors. They argue therefore that the lower standard of a mere prima facie case (rather than a "strong" or very strong" prima facie case) may be appropriate.

In essence, the fraud alleged is that the Investors were misled into thinking that the amount they paid for shares in Enigma or other Porton Portfolio Companies would, except for any usual commission, go to Enigma or the other Porton Portfolio Company in question, whereas in fact the majority of these monies (something like £61 million out of the £103 million raised) were retained by PCL.

The First Defendant denies this and points to the fact that the application forms used by Investors were clear that Investors were buying shares from PCL not directly subscribing for shares.

The Claimants cite the following matters as evidence for their claim in this regard.

The evidence of Mr Furber-Smith.

Mr Gavin Furber-Smith, who worked for PCL as a sales director between May 2005 and March 2012, has provided a detailed witness statement corroborated by instances of his communications to proposed Investors, in which he has detailed what Investors were told about the way the nominee arrangements would work. He is clear that:

He recalls Mr Boulter describing the allotment of shares to Porton and the sale to Investors as "back-to-back" transactions and that Mr Boulter had stated that the money would be sent to DLA who would pay it to the underlying companies with commissions being paid to Porton with the money raised.

He stated that he was often asked to explain the structure of the investment model and always answered as he was "directed to by Harvey" (that is Mr Boulter) that they were buying newly allotted shares in Enigma through a nominee platform and were sending their money to Enigma for Enigma's development purposes. He stated further that:

Of course this evidence has not been challenged in cross-examination but nevertheless, coming from a source that was central to PCL's operations, it is compelling evidence.

The evidence of Investors.

The Claimants also produced witness statements from a number of the Investors who invested in Enigma or other Porton Portfolio Companies or intermediaries representing such Investors, including a Mr Baker, Mr Clink, Mr Litster, Mr Al Roumi, Mr Shardlow, Mr Woods and Mr Temple. All these Investors confirmed that they had had a similar understanding that the purchase price they paid for shares in Enigma or another Porton Portfolio Company would be ultimately received by that company. Some of these witnesses are clearer than others as to the source of this understanding.

Mr Baker indicates that he derived that understanding from Mr Boulter and his team.

Mr Clink says that he was under the impression that the money he was investing was ultimately going to Enigma having been told by a representative of Porton that it was raising funding for Enigma and based on receiving presentations and memoranda that included statements regarding "Use of Funds" which implied that the funds raised would be used by Enigma for particular purposes.

Mr Litster says that:

Mr Al Roumi says that from meetings with Mr Boulter he understood that Porton was raising funds from Enigma and that funds raised would go towards developing Enigma's technology (although it appears that these discussions took place after his first investment in 2007).

Mr Shardlow cites an email from Darren Hughes at Porton, which included updates on Enigma and another Porton Portfolio Company called Cellcrypt and spoke of the funding round being necessary for the growth of the company.

Mr Woods was an Investor in Smart Holograms and Acolyte Direct Equity, two other Porton Portfolio Companies. He cannot remember the fine detail of his conversations with Gavin Hayman of Porton but his impression that the funds were to be raised for these companies was backed up by slides and business plans explaining the use of funds.

He later invested into Enigma, dealing with Mr Boulter and Augustus Greaves, and on the basis that this would raise funds for Enigma for product development and manufacturing. He cannot remember the conversation but it was clear to him that any investment he made was intended to meet the funding needs of Enigma.

Mr Temple's evidence is that his clear understanding that a share purchase would be invested into and received by Enigma was derived from Jim Armitage, a sales representative for Porton.

Contemporaneous documentation

The court was taken to multiple examples of exchanges of emails where Mr Boulter personally informed various Investors or their financial advisers that the monies they would be paying for shares in Enigma or various other Porton portfolio companies would be received by the company issuing the shares.

Application forms.

In approximately 130 out of some 1400 application forms, principally received between approximately mid 2010 and late 2011, the text which instructed Investors how to pay for the shares they were purchasing which began:

None of the Defendants have provided any explanation for this additional wording. However, to counter this it may be noted that in a larger number of application forms, around 500 principally received from late 2011 onwards, the text instead continued:

CONCLUSION

Taken individually holes can be picked in various of the items put forward by the Claimants as evidence for the proposition that Investors were misled. Indeed the Second and Third Defendants have itemised in their letter dated 30 May 2023 various points that could reasonably be made by way of criticism in relation to various witness statements and other documentation referred to. There is the evidence only of seven investors out of hundreds of investors.

Nevertheless, taken as a whole I consider that the evidence put together is impressive and compelling that PCL was systemically telling Investors that the monies paid to DLA Piper would go to Enigma or the other Porton portfolio companies whose shares were being purchased, whilst the truth was that it was in fact trading for its own purposes and kept a substantial proportion of the money, over 60 per cent overall, in the case of Enigma. Mr Furber- Smith's compelling direct evidence is backed up by the other evidence provided to the court. No clear evidence is before the court that suggests that Investors knew that PCL was selling on its own account at a profit.

Mr Kitchener rightly remarked on the point that if the First Defendant had any credible challenge to this evidence, he had had an opportunity to bring this challenge and had chosen not to and the court was entitled also to take this into account in judging the credibility of the case put forward in relation to investor fraud.

This body of evidence in my view is sufficient to provide a very good arguable case that DLA Piper's services were being used by PCL to assist PCL in a fraud on Investors. As such, I accept it as meeting the standard of demonstrating "iniquity" so that the court should conclude that PCL has no right to legal professional privilege in relation to material held by DLA Piper in providing its legal services to PCL in relation to sales of shares made using the services of DLA Piper.

I confirm therefore that I approve in principle the draft order and I will now ask Mr Kitchener to take me through the draft order in order to finalise it. I will also hear from the parties in relation to costs.